$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
028-123456789
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
medicaldrugs
medicaldrugs
Telisotuzumab-EMRELIS medical insurance reimbursement conditions and policy and cost explanations in different regions
2026-02-01 22:25:32
Check Details
Comparison of the efficacy of tovorafenib and trametinib, as well as treatment options and clinical references for different patients
2026-02-01 22:25:32
Check Details
Comparative analysis of the differences, indications, efficacy and use of vorasidenib-VORANIGO and fluconazole
2026-02-01 22:25:32
Check Details
Zongatinib (Zongatinib) launch time and patient purchase channel description
2026-02-01 22:25:32
Check Details
The price of vosoritide, the market reference cost for different courses of treatment and the description of the drug purchase plan
2026-02-01 22:25:32
Check Details
Recommended instructions for the correct usage, dosage and taking time of Mecobalamin tablets
2026-02-01 22:25:32
Check Details
Whether cobimetinib (cobimetinib) has officially entered the Chinese market and the progress of registration approval
2026-02-01 22:25:32
Check Details
How many years do you usually need to take macitentan (Aoposu)? Analysis of long-term treatment management plan
2026-02-01 22:25:32
Check Details
Comparison and recommendation of the effects of Prolixen and Tilorisen (Huacosi) in the treatment of narcolepsy
2026-02-01 22:25:32
Check Details
The longest time that talquetamab-tgvs can be taken and its safety
2026-02-01 22:25:32
Check Details
Types of diseases dupilumab/dalbitux are used to treat
2026-02-01 22:25:32
Check Details
Study on the Effect of Febuxostat/Febuxonide on Creatinine Levels
2026-02-01 22:25:32
Check Details
1
2
...
2288
2289
2290
2291
2292
2293
2294
...
2438
2439
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
User Agreement
2
Herceptin Hylecta treats HER2-positive breast cancer and only needs to be injected subcutaneously and only used once every three weeks
3
What is the most important information I should know about WELIREG?
4
How to take and store WELIREG
5
How to take TRUSELTIQ correctly
6
How to deal with LONSURF side effects (1)
7
How to deal with LONSURF side effects (2)
8
Cabozantinib (Cabometyx)-new indication approved
9
What should I pay attention to when using atezolizumab/Tecentriq?
10
Darzalex Faspro, Kyprolis and dexamethasone "three swords combined" to treat multiple myeloma
11
Rituximab combined with chemotherapy approved in the United States for pediatric patients with specific malignant tumors
12
Lenvatinib and pembrolizumab trial results in unresectable hepatocellular carcinoma